Deutsche Bank $1.75 billion notes offerings
The offerings included fixed-to-floating-rate and floating-rate eligible liabilities notes
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
UBS $1.25 billion senior notes offering
The investment-grade notes are due 2028
BBVA $1 billion preferred securities offering
We advised BBVA on its offering of contingent convertible perpetual preferred securities
Toyota Motor Credit $2.6 billion notes offering
We advised Toyota Motor Credit on the SEC-registered notes offering
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
CRH $3 billion guaranteed notes offering
The investment-grade notes are due 2030, 2035 and 2055
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
BrainAurora Medical Technology HK$583 million IPO
We advised BrainAurora on its IPO and HKEX listing
Veritas Technologies comprehensive debt recapitalization transaction
We advised an ad hoc group of term lenders and noteholders on the transaction